利用纯化的自体恶性和非恶性前列腺上皮细胞鉴定前列腺癌发生早期的新型致癌事件
研究对5例局限性前列腺癌患者的恶性与配对非恶性前列腺上皮细胞进行RNA测序,发现17个基因改变且82%下调,TDRD1、ANGTL4和CLDN3持续上调,3例有ERG信号上调但仅1例含TMPRSS2-ERG重排,未发现患者间一致的突变或剪接变异。
要点
- 前列腺癌早期以基因表达下调为主,17个改变基因中82%下调。
- TDRD1、ANGTL4和CLDN3在恶性组织中持续上调。
- 5例中3例ERG信号上调,但仅1例有TMPRSS2-ERG重排。
核心结论
- 这些样本中前列腺癌早期致癌事件以基因表达普遍下调为主,同时TDRD1、ANGTL4和CLDN3上调。
- 未观察到患者间一致的突变或剪接变异,但ERG信号上调可见于伴或不伴经典TMPRSS2-ERG重排的情况。
研究设计与样本
- 研究纳入5例前列腺腺癌累及单侧叶两个或以上连续区域的男性,采集恶性与配对非恶性前列腺切除标本。
- 组织经消化制成单细胞悬液,用磁珠分离上皮细胞黏附分子阳性细胞,确保每位供者获得均一细胞群。
- 采用无偏RNA测序分析基因表达,检测恶性前列腺上皮细胞相对自体对照上皮细胞中过表达或低表达的转录突变或剪接变异。
主要发现
- 从5例患者样本中鉴定出17个在前列腺癌上皮细胞中改变的基因,其中82%的基因下调。
- TDRD1、ANGTL4和CLDN3三个基因在恶性组织中持续上调。
- 5例患者中3例的恶性细胞显示ERG信号上调证据,但其中仅1例含有TMPRSS2-ERG重排。
- 未鉴定出患者间一致的突变、基因重排或剪接变异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To interrogate enriched prostate cancer cells and autologous non-malignant prostate epithelial cells from men with localized prostate cancer, in order to identify early oncogenic pathways. PATIENTS AND METHODS: We collected malignant and matched non-malignant prostatectomy samples from men with adenocarcinoma involving two or more contiguous areas in only one lobe of the prostate. Tissue samples from both lobes were subjected to digestion and single-cell suspensions were prepared. Epithelial cell adhesion molecule-positive cells from cancerous and contralateral non-malignant (control) samples were isolated using magnetic beads, ensuring uniform populations were obtained for each donor. Unbiased RNA sequencing analysis was used to measure gene expression and for detection of transcribed mutations or splice variants that were over- or under-represented in malignant prostate epithelial cells relative to autologous control prostate epithelial cells. RESULTS: From five patient samples we identified 17 genes that were altered in prostate cancer epithelial cells, with 82% of genes being downregulated. Three genes, TDRD1, ANGTL4, and CLDN3, were consistently upregulated in malignant tissue. Malignant cells from three of the five patients showed evidence of upregulated ERG signalling, however, only one of these contained a TMPRSS2-ERG rearrangement. We did not identify mutations, gene rearrangements, or splice variants that were consistent amongst the patients. CONCLUSIONS: Events occurring early in prostate cancer oncogenesis in these samples were characterized by a predominant downregulation of gene expression along with upregulation of TDRD1, ANGTL4 and CLDN3. No consistent mutations or splice variants were observed, but upregulation of ERG signalling was seen both in the presence and absence of the classic TMPRSS2-ERG rearrangement.
引用
- Sluka P, Pezaro C, Wardan H, et al. Identification of novel oncogenic events occurring early in prostate carcinogenesis using purified autologous malignant and non-malignant prostate epithelial cells. BJU Int. 2019. PMID: 30712320. doi:10.1111/bju.14695
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。